Nuradh Joseph

The Clinical Approach to Salvage Treatment of Locoregional #Tumour #Recurrence - co-authored with #whereishoskin published in @ClinOncology @MCRCnews @MVCCbrachy @RCRadiologists #radonc #cancer #oncology sciencedirect.com/science/articl…

👏🏻Congratulations to Prof. Chandima Jeewandara on being appointed the first Director of the Institute of Allergology and Immunology. 🔬A landmark moment for our newly established institute at @usjp, advancing immunology, allergology, molecular medicine & biomedical engineering.

@sanjanah @slconcology @Gunti777 Thanks @sanjanah for making time for us. You probably save more lives with your ground-breaking work on disinformation!!

Healthcare & hashtags - a delicate balance An insightful keynote at the @slconcology annual meeting by the brilliant @sanjanah on #medical #disinformation on #socialmedia which spreads like cancer & metastatises in society leaving an incurable legacy of harm #srilanka @Gunti777

@gerryhanna joins us virtually with a illuminating talk on practical aspects of #radiotherapy in #NSCLC at the @slconcology annual meeting. #SriLanka #lungcancer

An early morning for #whereishoskin as he kicks off the @slconcology annual meeting with a breakfast session on #cancerresearch Lots of practical tips and wisdom from the legend himself.. Hope this translates into more #cancerresearch in #SriLanka @MCRCnews @hiprabs #oncology

GLP-1 Receptor Agonists are powerful new💉 in assising weight loss, but do they cause cancer? Just out in @JAMAOnc study in people from Florida with obesity ➡️Bottom line cancer incidence is lower overall in those taking GLP-1RA (HR=0.83 0.76-0.91) 🔗jamanetwork.com/journals/jamao…

Our paper on Ensuring sustainable funding for novel #cancer #therapeutics through a budget impact analysis in #LMICs - published in #ecancer #SriLanka #healtheconomics #globaloncology #oncology @Vimukthini @prasaday @vodathi @nadajeyakumaran @Gunti777 ecancer.org/en/journal/art…

THE conference where everyone brought their A-game! 1st ever APCCC South Asia 🇮🇳🇱🇰🇳🇵🇧🇩 edition😇 Fortunate to be a part of wonderfully exhaustive discussion s on everything in prostate cancer!

Thanks so much @VedangMurthy for putting together the first ever #APCCC #SouthAsia and for including #SriLanka. It was great to meet so many colleagues from #SouthAsia #Prostatecancer #oncology @Vimukthini @YasiruMalinda @docpriyamvada

Finally Managed to gather a fantastic bunch of KOLs from India 🇮🇳 Bangladesh Sri Lanka and Nepal. Discussed the nuances of PCa Mx. Plenty of friendly banter and leg pulling. Official APCCC South Asia. Paper with similarities yet differences from @APCCC_Lugano coming soon.

#Repurposing Medications for #PalliativeCare - An insightful review authored by Sudhakaran, Das and Kondasinghe published in #RCROpen @RCRadiologists Useful practical tips for all #clinicians! #oncology #cancer @ClinOncology @OncologyAdvance sciencedirect.com/science/articl…

Results from FAST-Forward Nodal substudy published in @RO_GreenJournal ➡️26 Gy/5Fr non-inferior to 40 Gy/15Fr for hand swelling at 5 years ➡️No cases of radiation-induced brachial plexopathy ➡️Other patient-reported outcomes were similar 🔗doi.org/10.1016/j.rado…

A superb webinar hosted tomorrow by our own Discipline of Radiation Therapy @tcddublin featuring @JoanneLysaght on #immunotherapy and #Radiotherapy - two potentially powerful allies in anti-cancer treatment. Sign up here 👉tcd-ie.zoom.us/webinar/regist…

I was chosen, without any merit of my own. Now, with fear and trembling, I come to you as a brother, who desires to be the servant of your faith and joy, walking with you on the path of God’s love, for He wants us all to be united in one family.

Big news from #ESTRO25! Nivolumab + CRT shows striking improvement in MIBC outcomes for patients not undergoing RC! BCFFS: 70.3% vs 43.4% OS at 2y: 86.8% vs 60.5% (p=0.005) Well tolerated + good onc outcomes = a game-changer? Time for Phase III trial! #TMT #MIBC #immunotherapy

🎥 Prof Murray Brunt (Keele University, UK) spoke to us about the FAST-Forward trial, presented last Saturday at #ESTRO25. The 10-year results show that 1-week #breastcancer #radiotherapy is safe, effective, and improves patient #qualityoflife.

"Routine Surveillance for Cancer Metastases — Does It Help or Harm Patients?" This short paper in today's @NEJM suggests that routine scanning/surveillance is not beneficial and maybe harmful in some cases. Food for thought... 🔗nejm.org/doi/full/10.10…

Pope Francis has left us — a shepherd who carried Gaza in his prayers, Sudan in his heart. Even in his final days, he spoke for the broken, the bombed, the forgotten. A holy soul now at rest, but still walking with the wounded. The world is a lesser place today. Rest in power